Stock A009420 HANALL BIOPHARMA CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Comparison Chart Hanall Biopharma Co., Ltd.

Equities

A009420

KR7009420001

End-of-day quote Korea S.E.
Other stock markets
 06:00:00 2024-07-15 pm EDT 		5-day change 1st Jan Change
36,750 KRW -2.65% Intraday chart for Hanall Biopharma Co., Ltd. +9.05% -17.04%
Jul. 15 Hanall Biopharma Co., Ltd. Appoints Christopher W Slavinsky as Chief Business Development and Legal Officer CI
May. 14 Hanall Biopharma Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Compared values

Sector Change 5d. change 1st Jan change 1-year change 5-years change Capi. ST MT LT
HANALL BIOPHARMA CO., LTD.
Other Pharmaceuticals
-2.65%+9.05%-17.04%+84.58%+34.62% 1.34B
Bullish
Neutral
Neutral

Technical Rankings Surperformance

  1. Stock Market
  2. Equities
  3. A009420 Stock
  4. Charts Hanall Biopharma Co., Ltd.
  5. Comparison Chart